Dual specificity phosphatase 4 (DUSP4; MKP2); c-jun N-terminal kinase (JNK); MEK BriefCommunication Pages: 1020 - 1020
Enhancer of zeste homolog 2 (EZH2); embryonic ectoderm development (EED) BriefCommunication Pages: 1023 - 1023
v-Maf musculoaponeurotic fibrosarcoma oncogene homolog A (MAFA; RIPE3b1); microRNA-204 (miR-204) BriefCommunication Pages: 1030 - 1030
Glutathione peroxidase 1 (GPX1); glutathione peroxidase 3 plasma (GPX3) BriefCommunication Pages: 1037 - 1037
Highly specific, recombinant antibodies to detect histone H3 trimethylation BriefCommunication Pages: 1038 - 1038
A computational model to reconstruct network effects of microRNAs and identify targets BriefCommunication Pages: 1040 - 1040
A doxycycline-inducible serum amyloid A (SAA) transgenic mouse model of systemic amyloidosis BriefCommunication Pages: 1041 - 1041
Collection of haploid human isogeneic cell lines with mutations in individual genes BriefCommunication Pages: 1043 - 1043
Mice with epidermal-specific knockout of epidermal growth factor receptor (Egfr) to model skin toxicity associated with EGFR-targeted cancer therapy BriefCommunication Pages: 1044 - 1044
Monitoring response to preventive therapy in patients with Huntington's disease (HD) using 18F-labeled fluorodeoxyglucose PET (FDG-PET) imaging BriefCommunication Pages: 1045 - 1045
Measuring CD8 + T cell tumor infiltration to guide immunotherapy selection BriefCommunication Pages: 1047 - 1047
Single lipid vesicle assay to measure hydrolysis of disease-associated phospholipids BriefCommunication Pages: 1048 - 1048